Literature DB >> 26669782

A spontaneous metastasis model reveals the significance of claudin-9 overexpression in lung cancer metastasis.

Rajesh K Sharma1,2,3, Zinal S Chheda4, Biswa Pratim Das Purkayastha5, Jorge G Gomez-Gutierrez6, Venkatakrishna R Jala5,4, Bodduluri Haribabu7,8.   

Abstract

Metastasis causes most cancer related mortality but the mechanisms governing metastatic dissemination are poorly defined. Metastasis involves egression of cancer cells from the primary tumors, their survival in circulation and colonization at the secondary sites. Cancer cell egression from the primary tumor is the least defined process of metastasis as experimental metastasis models directly seed cancer cells in circulation, thus bypassing this crucial step. Here, we developed a spontaneous metastasis model that retains the egression step of metastasis. By repeated in vivo passaging of the poorly metastatic Lewis lung carcinoma (3LL) cells, we generated a cell line (p-3LL) that readily metastasizes to lungs and liver from subcutaneous (s.c.) tumors. Interestingly, when injected intravenously, 3LL and p-3LL cells showed a similar frequency of metastasis. This suggests enhanced egression of p-3LL cells may underlie the enhanced metastatic spread from primary tumors. Microarray analysis of 3LL and p-3LL cells as well as the primary tumors derived from these cells revealed altered expression of several genes including significant upregulation of a tight junction protein, claudin-9. Increased expression of claudin-9 was confirmed in both p-3LL cells and tumors derived from these cells. Knockdown of claudin-9 expression in p-3LL cells by si-RNA significantly reduced their motility, invasiveness in vitro and metastasis in vivo. Conversely, transient overexpression of claudin-9 in 3LL cells enhanced their motility. These results suggest an essential role for claudin-9 in promoting lung cancer metastasis.

Entities:  

Keywords:  Biomarker; Claudin-9; Lung Cancer; Metastasis; Migration

Mesh:

Substances:

Year:  2015        PMID: 26669782     DOI: 10.1007/s10585-015-9776-4

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  54 in total

1.  Atypical non-small cell lung cancer presentation: inguinal lymph node metastases as the first sign of disease relapse.

Authors:  Leo Grandić; Zenon Pogorelić; Josip Banović; Gea Forempoher; Nenad Ilić; Zdravko Perko
Journal:  Acta Clin Croat       Date:  2010-12       Impact factor: 0.780

Review 2.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

3.  Nuclear distribution of claudin-2 increases cell proliferation in human lung adenocarcinoma cells.

Authors:  Akira Ikari; Ryo Watanabe; Tomonari Sato; Saeko Taga; Shun Shimobaba; Masahiko Yamaguchi; Yasuhiro Yamazaki; Satoshi Endo; Toshiyuki Matsunaga; Junko Sugatani
Journal:  Biochim Biophys Acta       Date:  2014-06-04

4.  Liver metastasis at the time of initial diagnosis of lung cancer.

Authors:  Katsunori Kagohashi; Hiroaki Satoh; Hiroichi Ishikawa; Morio Ohtsuka; Kiyohisa Sekizawa
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

5.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.

Authors:  A Bhattacharjee; W G Richards; J Staunton; C Li; S Monti; P Vasa; C Ladd; J Beheshti; R Bueno; M Gillette; M Loda; G Weber; E J Mark; E S Lander; W Wong; B E Johnson; T R Golub; D J Sugarbaker; M Meyerson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

Review 6.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

Review 7.  The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis.

Authors:  Sandra S McAllister; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2014-08       Impact factor: 28.824

8.  Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth.

Authors:  Shuchismita R Satpathy; Venkatakrishna R Jala; Sobha R Bodduluri; Elangovan Krishnan; Bindu Hegde; Gary W Hoyle; Mostafa Fraig; Andrew D Luster; Bodduluri Haribabu
Journal:  Nat Commun       Date:  2015-04-29       Impact factor: 14.919

9.  Claudin-4 expression in gastric cancer cells enhances the invasion and is associated with the increased level of matrix metalloproteinase-2 and -9 expression.

Authors:  Tsann-Long Hwang; Tzu-Tsung Changchien; Chee-Chan Wang; Chi-Ming Wu
Journal:  Oncol Lett       Date:  2014-06-27       Impact factor: 2.967

10.  MYC is a metastasis gene for non-small-cell lung cancer.

Authors:  Ulf R Rapp; Christian Korn; Fatih Ceteci; Christiaan Karreman; Katharina Luetkenhaus; Valentina Serafin; Emanuele Zanucco; Inês Castro; Tamara Potapenko
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240

View more
  4 in total

Review 1.  For robust big data analyses: a collection of 150 important pro-metastatic genes.

Authors:  Yan Mei; Jun-Ping Yang; Chao-Nan Qian
Journal:  Chin J Cancer       Date:  2017-01-21

Review 2.  Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk.

Authors:  Ajaz A Bhat; Srijayaprakash Uppada; Iman W Achkar; Sheema Hashem; Santosh K Yadav; Muralitharan Shanmugakonar; Hamda A Al-Naemi; Mohammad Haris; Shahab Uddin
Journal:  Front Physiol       Date:  2019-01-23       Impact factor: 4.566

Review 3.  Mouse Models of Human Claudin-Associated Disorders: Benefits and Limitations.

Authors:  Murat Seker; Carmen Fernandez-Rodriguez; Luis Alfonso Martinez-Cruz; Dominik Müller
Journal:  Int J Mol Sci       Date:  2019-11-05       Impact factor: 5.923

4.  Claudin‑9 is a novel prognostic biomarker for endometrial cancer.

Authors:  Yuta Endo; Kotaro Sugimoto; Makoto Kobayashi; Yasuyuki Kobayashi; Manabu Kojima; Shigenori Furukawa; Shu Soeda; Takafumi Watanabe; Atsuko Y Higashi; Tomohito Higashi; Yuko Hashimoto; Keiya Fujimori; Hideki Chiba
Journal:  Int J Oncol       Date:  2022-09-21       Impact factor: 5.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.